Author

Kostantinos Toskas

Karolinska Institutet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Eirini AntoniouiD· 1 shared Henrik LindehelliD· 1 shared Ilknur Safak Demirel· 1 shared Iria Laura MartineziD· 1 shared Jakob J. E. StenmaniD· 1 shared Jiacheng ZhuiD· 1 shared Johan HolmbergiD· 1 shared Jonas MuhriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Eirini AntoniouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma.

Juan Yuan, Subhamita Maitra, Eirini Antoniou, Jiacheng Zhu, Wenyu Li, Ilknur Safak Demirel, Kostantinos Toskas, Iria Laura Martinez, Lacin Ozcimen, Henrik Lindehell, Jonas Muhr, Jakob J. E. Stenman, Per Kogner, Oscar C. Bedoya-Reina, Susanne Schlisio, Johan Holmberg

This paper shows that HIF2α reduces MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma, suggesting HIF2 has tumor suppressor rather than oncogenic function.

Proceedings of the National Academy of Sciences · Oct 21, 2025Peer-reviewedCancer Biology